Selected research
Industry Research
Solid Tumors Target Proteins Industry Research Report 2026
Market perspective
The global Solid Tumors Target Proteins market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Solid Tumors Target Proteins market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Solid Tumors Target Proteins market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Solid Tumors Target Proteins market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Solid Tumors Target Proteins include Novartis, Sino Biological, ACRO Biosystems, TargetMol Chemicals, ProteoGenix, Kite Pharma, Kactus Biosystems, Juno Therapeutics and Elabscience, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Solid Tumors Target Proteins market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Solid Tumors Target Proteins.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Solid Tumors Target Proteins Market by Company
Novartis
Sino Biological
ACRO Biosystems
TargetMol Chemicals
ProteoGenix
Kite Pharma
Kactus Biosystems
Juno Therapeutics
Elabscience
Creative BioMart
Creative Biolabs
Bio-Techne
Bio X Cell
ACROBiosystems
Solid Tumors Target Proteins Segment by Type
EGFR Protein
HER2 Protein
Others
Solid Tumors Target Proteins Segment by Application
Hospital
Biological Laboratory
Others
Solid Tumors Target Proteins Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Solid Tumors Target Proteins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Solid Tumors Target Proteins and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Solid Tumors Target Proteins.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Solid Tumors Target Proteins companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- EGFR Protein
- HER2 Protein
- Others
Applications
- Hospital
- Biological Laboratory
- Others
Companies covered
- Novartis
- Sino Biological
- ACRO Biosystems
- TargetMol Chemicals
- ProteoGenix
- Kite Pharma
- Kactus Biosystems
- Juno Therapeutics
- Elabscience
- Creative BioMart
- Creative Biolabs
- Bio-Techne
- Bio X Cell
- ACROBiosystems
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Solid Tumors Target Proteins by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 EGFR Protein
- 2.2.3 HER2 Protein
- 2.2.4 Others
- 2.3 Solid Tumors Target Proteins by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Biological Laboratory
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Solid Tumors Target Proteins Breakdown Data by Type
- 3.1 Global Solid Tumors Target Proteins Historic Market Size by Type (2021-2026)
- 3.2 Global Solid Tumors Target Proteins Forecasted Market Size by Type (2027-2032)
4 Solid Tumors Target Proteins Breakdown Data by Application
- 4.1 Global Solid Tumors Target Proteins Historic Market Size by Application (2021-2026)
- 4.2 Global Solid Tumors Target Proteins Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Solid Tumors Target Proteins Market Perspective (2021-2032)
- 5.2 Global Solid Tumors Target Proteins Growth Trends by Region
- 5.2.1 Global Solid Tumors Target Proteins Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Solid Tumors Target Proteins Historic Market Size by Region (2021-2026)
- 5.2.3 Solid Tumors Target Proteins Forecasted Market Size by Region (2027-2032)
- 5.3 Solid Tumors Target Proteins Market Dynamics
- 5.3.1 Solid Tumors Target Proteins Industry Trends
- 5.3.2 Solid Tumors Target Proteins Market Drivers
- 5.3.3 Solid Tumors Target Proteins Market Challenges
- 5.3.4 Solid Tumors Target Proteins Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Solid Tumors Target Proteins Players by Revenue
- 6.1.1 Global Top Solid Tumors Target Proteins Players by Revenue (2021-2026)
- 6.1.2 Global Solid Tumors Target Proteins Revenue Market Share by Players (2021-2026)
- 6.2 Global Solid Tumors Target Proteins Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Solid Tumors Target Proteins Head Office and Area Served
- 6.4 Global Solid Tumors Target Proteins Players, Product Type & Application
- 6.5 Global Solid Tumors Target Proteins Manufacturers Established Date
- 6.6 Global Solid Tumors Target Proteins Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Solid Tumors Target Proteins Market Size (2021-2032)
- 7.2 North America Solid Tumors Target Proteins Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Solid Tumors Target Proteins Market Size by Country (2021-2026)
- 7.4 North America Solid Tumors Target Proteins Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Solid Tumors Target Proteins Market Size (2021-2032)
- 8.2 Europe Solid Tumors Target Proteins Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Solid Tumors Target Proteins Market Size by Country (2021-2026)
- 8.4 Europe Solid Tumors Target Proteins Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Solid Tumors Target Proteins Market Size (2021-2032)
- 9.2 Asia-Pacific Solid Tumors Target Proteins Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Solid Tumors Target Proteins Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Solid Tumors Target Proteins Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Solid Tumors Target Proteins Market Size (2021-2032)
- 10.2 South America Solid Tumors Target Proteins Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Solid Tumors Target Proteins Market Size by Country (2021-2026)
- 10.4 South America Solid Tumors Target Proteins Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Solid Tumors Target Proteins Market Size (2021-2032)
- 11.2 Middle East & Africa Solid Tumors Target Proteins Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Solid Tumors Target Proteins Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Solid Tumors Target Proteins Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Novartis
- 12.1.1 Novartis Company Information
- 12.1.2 Novartis Business Overview
- 12.1.3 Novartis Revenue in Solid Tumors Target Proteins Business (2021-2026)
- 12.1.4 Novartis Solid Tumors Target Proteins Product Portfolio
- 12.1.5 Novartis Recent Developments
- 12.2 Sino Biological
- 12.2.1 Sino Biological Company Information
- 12.2.2 Sino Biological Business Overview
- 12.2.3 Sino Biological Revenue in Solid Tumors Target Proteins Business (2021-2026)
- 12.2.4 Sino Biological Solid Tumors Target Proteins Product Portfolio
- 12.2.5 Sino Biological Recent Developments
- 12.3 ACRO Biosystems
- 12.3.1 ACRO Biosystems Company Information
- 12.3.2 ACRO Biosystems Business Overview
- 12.3.3 ACRO Biosystems Revenue in Solid Tumors Target Proteins Business (2021-2026)
- 12.3.4 ACRO Biosystems Solid Tumors Target Proteins Product Portfolio
- 12.3.5 ACRO Biosystems Recent Developments
- 12.4 TargetMol Chemicals
- 12.4.1 TargetMol Chemicals Company Information
- 12.4.2 TargetMol Chemicals Business Overview
- 12.4.3 TargetMol Chemicals Revenue in Solid Tumors Target Proteins Business (2021-2026)
- 12.4.4 TargetMol Chemicals Solid Tumors Target Proteins Product Portfolio
- 12.4.5 TargetMol Chemicals Recent Developments
- 12.5 ProteoGenix
- 12.5.1 ProteoGenix Company Information
- 12.5.2 ProteoGenix Business Overview
- 12.5.3 ProteoGenix Revenue in Solid Tumors Target Proteins Business (2021-2026)
- 12.5.4 ProteoGenix Solid Tumors Target Proteins Product Portfolio
- 12.5.5 ProteoGenix Recent Developments
- 12.6 Kite Pharma
- 12.6.1 Kite Pharma Company Information
- 12.6.2 Kite Pharma Business Overview
- 12.6.3 Kite Pharma Revenue in Solid Tumors Target Proteins Business (2021-2026)
- 12.6.4 Kite Pharma Solid Tumors Target Proteins Product Portfolio
- 12.6.5 Kite Pharma Recent Developments
- 12.7 Kactus Biosystems
- 12.7.1 Kactus Biosystems Company Information
- 12.7.2 Kactus Biosystems Business Overview
- 12.7.3 Kactus Biosystems Revenue in Solid Tumors Target Proteins Business (2021-2026)
- 12.7.4 Kactus Biosystems Solid Tumors Target Proteins Product Portfolio
- 12.7.5 Kactus Biosystems Recent Developments
- 12.8 Juno Therapeutics
- 12.8.1 Juno Therapeutics Company Information
- 12.8.2 Juno Therapeutics Business Overview
- 12.8.3 Juno Therapeutics Revenue in Solid Tumors Target Proteins Business (2021-2026)
- 12.8.4 Juno Therapeutics Solid Tumors Target Proteins Product Portfolio
- 12.8.5 Juno Therapeutics Recent Developments
- 12.9 Elabscience
- 12.9.1 Elabscience Company Information
- 12.9.2 Elabscience Business Overview
- 12.9.3 Elabscience Revenue in Solid Tumors Target Proteins Business (2021-2026)
- 12.9.4 Elabscience Solid Tumors Target Proteins Product Portfolio
- 12.9.5 Elabscience Recent Developments
- 12.10 Creative BioMart
- 12.10.1 Creative BioMart Company Information
- 12.10.2 Creative BioMart Business Overview
- 12.10.3 Creative BioMart Revenue in Solid Tumors Target Proteins Business (2021-2026)
- 12.10.4 Creative BioMart Solid Tumors Target Proteins Product Portfolio
- 12.10.5 Creative BioMart Recent Developments
- 12.11 Creative Biolabs
- 12.11.1 Creative Biolabs Company Information
- 12.11.2 Creative Biolabs Business Overview
- 12.11.3 Creative Biolabs Revenue in Solid Tumors Target Proteins Business (2021-2026)
- 12.11.4 Creative Biolabs Solid Tumors Target Proteins Product Portfolio
- 12.11.5 Creative Biolabs Recent Developments
- 12.12 Bio-Techne
- 12.12.1 Bio-Techne Company Information
- 12.12.2 Bio-Techne Business Overview
- 12.12.3 Bio-Techne Revenue in Solid Tumors Target Proteins Business (2021-2026)
- 12.12.4 Bio-Techne Solid Tumors Target Proteins Product Portfolio
- 12.12.5 Bio-Techne Recent Developments
- 12.13 Bio X Cell
- 12.13.1 Bio X Cell Company Information
- 12.13.2 Bio X Cell Business Overview
- 12.13.3 Bio X Cell Revenue in Solid Tumors Target Proteins Business (2021-2026)
- 12.13.4 Bio X Cell Solid Tumors Target Proteins Product Portfolio
- 12.13.5 Bio X Cell Recent Developments
- 12.14 ACROBiosystems
- 12.14.1 ACROBiosystems Company Information
- 12.14.2 ACROBiosystems Business Overview
- 12.14.3 ACROBiosystems Revenue in Solid Tumors Target Proteins Business (2021-2026)
- 12.14.4 ACROBiosystems Solid Tumors Target Proteins Product Portfolio
- 12.14.5 ACROBiosystems Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst